Bill > S2109

This bill prohibits health benefit plans, which are insurance policies that cover medical expenses, and pharmacy benefit managers, companies that manage prescription drug benefits for health plans, from reviewing or requiring pre-approval for certain medications used to treat alcohol or opioid addiction. Specifically, this applies to drugs containing methadone, buprenorphine, or naltrexone, as well as any medication approved by the U.S. Food and Drug Administration for managing alcohol or opioid addiction or for alleviating symptoms of opioid withdrawal. The bill also amends the Medical Assistance program, commonly known as Medicaid, to ensure that managed care organizations use specific medical necessity criteria established by the executive office of health and human services when reviewing treatment for these disorders. These changes are intended to streamline access to essential addiction treatments and will take effect immediately upon being passed into law.

Health and Social Services

https://status.rilegislature.gov/